-
Viral Infections
- COVID-19
- MERS-CoV
- Ebola
-
Hepatitis
-
HIDIT II
A multicenter randomized study comparing the efficacy of pegylated interferon-alfa-2a plus placebo vs. pegylated interferon-alfa-2a plus tenofovir for the treatment of chronic delta hepatitis The Hep-Net International Delta Hepatitis Interventional Trial II
-
OPTEX 2/3
OPtimization of treatment for patients with chronic hepatitis C infected with HCVgenotype 2 or 3: 12 vs. 24 weeks of Treatment EXtension for patients without rapid virological response (OPTEX 2/3)
-
Tobira (CENTAUR)
CENTAUR: Cenicriviroc Efficacy and Safety Study in Adult Subjects with Nonalcoholic Steatohepatitis (NASH)
-
HIDIT II
- HIV / AIDS
- Influenza
- Varizella zoster
- Bacterial Infections
- Infections in the immunocompromised host
- Invasive fungal infections
- Gastrointestinal infections
- Parasitic diseases
- de
- en